Product Beschrijving

1cP-LSD Art Blotters 100mcg

1cP-LSD Art Blotters 100mcg is a synthetic lysergamide and prodrug of LSD. It is not approved for medical use and is classified as a novel psychoactive substance (NPS). The following is a neutral summary of available safety information based on scientific literature, user reports, and predictive toxicology data.

Pharmacology & Metabolism

1cP-LSD has lower direct affinity for serotonin 5-HT2A receptors due to the cyclopropanoyl group at the N1 position. After ingestion, it is metabolized (primarily via hydrolysis) into active LSD. This conversion is believed to be relatively efficient, leading to effects that are qualitatively similar to LSD. A 100mcg dose is commonly described as a moderate recreational dose, roughly comparable to a light-to-moderate LSD experience after conversion.

Acute veiligheidsprofiel

• Physiological Toxicity: LSD itself has a very high safety margin with no well-documented cases of direct fatal overdose from the substance alone, even at high doses. Estimated lethal dose is extremely high (thousands of times a typical recreational dose). Acute physical effects may include increased heart rate, blood pressure, pupil dilation, muscle tension, and nausea.
• Psychological Risks: The primary safety concerns are psychological. Possible effects include intense anxiety, panic attacks, paranoia, confusion, and challenging experiences (“bad trips”). Individuals with a personal or family history of psychosis, schizophrenia, or severe anxiety disorders may be at higher risk of adverse psychological reactions.

Mogelijke bijwerkingen

• Short-term: Dizziness, headaches, insomnia, fatigue during comedown, and temporary perceptual changes.
• Rare but reported: Hallucinogen Persisting Perception Disorder (HPPD) — ongoing visual disturbances after use.
• Unknown long-term effects due to limited clinical research on 1cP-LSD specifically.

In Silico Toxicology Predictions

Computational (computer-modelled) studies on 1cP-LSD and similar analogs have flagged potential concerns including:

• Elevated risk of pulmonary toxicity
• Possible genotoxicity signals
• Cardiotoxicity (hERG channel inhibition) and renal effects

These are predictive models only and have not been confirmed in human or animal studies.

Geneesmiddelinteracties en contra-indicaties

• Hoog risico: Combining with other serotonergic substances (SSRIs, MAOIs, MDMA, etc.) may increase risk of serotonin syndrome.
• Voorzichtigheid: Use with stimulants, cannabis, or alcohol can intensify effects unpredictably.
• Not recommended for people with cardiovascular conditions, mental health disorders, or during pregnancy/breastfeeding.

Product-Related Risks

As an unregulated research chemical sold on “art blotters,” concerns include:

• Inaccurate dosing
• Variable purity and possible contaminants
• Inconsistent conversion efficiency to LSD

Juridische Status

1cP-LSD is controlled or banned in many countries (including much of Europe, UK, Australia). In some jurisdictions, it exists in a legal gray area but may still fall under analogue laws if intended for human consumption.

Belangrijke Opmerking: This overview is for informational and educational purposes only. It is not medical advice and does not encourage use. Due to the limited human clinical data available on 1cP-LSD, significant uncertainties remain regarding both short- and long-term safety. Individuals considering any psychoactive substance should consult qualified healthcare professionals and carefully evaluate legal and health risks in their jurisdiction.

Aanvullende Informatie